189 related articles for article (PubMed ID: 33426814)
1. A quantitative model for metabolic intervention using gut microbes.
Mays ZJS; Nair NU
Biotechnol Prog; 2021 Sep; 37(5):e3125. PubMed ID: 33426814
[TBL] [Abstract][Full Text] [Related]
2. A prospective population pharmacokinetic analysis of sapropterin dihydrochloride in infants and young children with phenylketonuria.
Qi Y; Mould DR; Zhou H; Merilainen M; Musson DG
Clin Pharmacokinet; 2015 Feb; 54(2):195-207. PubMed ID: 25338975
[TBL] [Abstract][Full Text] [Related]
3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
4. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption.
Yu LX; Lipka E; Crison JR; Amidon GL
Adv Drug Deliv Rev; 1996 Jun; 19(3):359-76. PubMed ID: 11540095
[TBL] [Abstract][Full Text] [Related]
5. Living Therapeutics: The Next Frontier of Precision Medicine.
Kelly VW; Liang BK; Sirk SJ
ACS Synth Biol; 2020 Dec; 9(12):3184-3201. PubMed ID: 33205966
[TBL] [Abstract][Full Text] [Related]
6. Detection of Paracetamol as substrate of the gut microbiome.
Mukhtar I; Anwar H; Hussain G; Rasul A; Naqvi SAR; Faisal MN; Mustafa I; Malik S; Shaukat A; Mirza OA; Sohail MU
Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):751-757. PubMed ID: 31103967
[TBL] [Abstract][Full Text] [Related]
7. Efficient protection of microorganisms for delivery to the intestinal tract by cellulose sulphate encapsulation.
Gunzburg WH; Aung MM; Toa P; Ng S; Read E; Tan WJ; Brandtner EM; Dangerfield J; Salmons B
Microb Cell Fact; 2020 Nov; 19(1):216. PubMed ID: 33243224
[TBL] [Abstract][Full Text] [Related]
8. Modulating Oral Delivery and Gastrointestinal Kinetics of Recombinant Proteins via Engineered Fungi.
Heavey MK; Anselmo AC
AAPS J; 2021 May; 23(4):76. PubMed ID: 34009532
[TBL] [Abstract][Full Text] [Related]
9. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Physiologically Based Pharmacokinetic Models to Predict the Absorption of BCS Class I Drugs in Different Pediatric Age Groups.
Liu XI; van den Anker JN; Burckart GJ; Dallmann A
J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S94-S107. PubMed ID: 34185902
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients.
Li L; Wu H; Chen Y; Yuan H; Wu J; Wu X; Zhang Y; Cao G; Guo B; Wu J; Zhao M; Zhang J
Clin Ther; 2020 May; 42(5):818-829. PubMed ID: 32389326
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip.
Nelson MT; Charbonneau MR; Coia HG; Castillo MJ; Holt C; Greenwood ES; Robinson PJ; Merrill EA; Lubkowicz D; Mauzy CA
Nat Commun; 2021 May; 12(1):2805. PubMed ID: 33990606
[TBL] [Abstract][Full Text] [Related]
13. Can a Bug in the Gut Act Like a Drug in the Brain?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2015 Oct; 53(10):22-4. PubMed ID: 26489100
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol™)-application of a new "physiologically based" model to assess absorption and disposition.
Wang Y; Wang Z; Zuo Z; Tomlinson B; Lee BT; Bolger MB; Chow MS
AAPS J; 2013 Jul; 15(3):787-96. PubMed ID: 23605805
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.
Dong M; Fukuda T; Cox S; de Vries MT; Hooper DK; Goebel J; Vinks AA
Br J Clin Pharmacol; 2014 Nov; 78(5):1102-12. PubMed ID: 24837828
[TBL] [Abstract][Full Text] [Related]
16. The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs.
Stojančević M; Bojić G; Salami HA; Mikov M
Curr Issues Mol Biol; 2014; 16():55-68. PubMed ID: 24002548
[TBL] [Abstract][Full Text] [Related]
17. A multiscale absorption and transit model for oral drug delivery: Formulation and applications during fasting conditions.
Kannan R; Przekwas A
Int J Numer Method Biomed Eng; 2020 Mar; 36(3):e3317. PubMed ID: 32011090
[TBL] [Abstract][Full Text] [Related]
18. Physiologically Based Oral Absorption Modelling to Study Gut-Level Drug Interactions.
Chung J; Kesisoglou F
J Pharm Sci; 2018 Jan; 107(1):18-23. PubMed ID: 28847476
[TBL] [Abstract][Full Text] [Related]
19. A transit compartment model unmasks OxyContin's reflective pharmacokinetics from urine measurements in humans.
Linares OA; Schiesser WE; Linares AD; Stefanovski D; Boston RC
J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):96-108. PubMed ID: 24813654
[TBL] [Abstract][Full Text] [Related]
20. Delivery to the gut microbiota: A rapidly proliferating research field.
Seifert A; Kashi Y; Livney YD
Adv Colloid Interface Sci; 2019 Dec; 274():102038. PubMed ID: 31683191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
